Groundbreaking: USA News about Novartis, Roche & AstraZeneca
Some in the USA rare disease community were wondering how this scenario would unfold - now we know. Well, at least…
Can aHUS treatment be affordable for all?
A very important topic for many aHUS patients around the world with an unmet need. Patients have included the topic in…